Global Agencies Track 3 Avian Flu Strains After 71 U.S. H5N1 Cases
Updated
Updated · Medical Daily · Jul 1
Global Agencies Track 3 Avian Flu Strains After 71 U.S. H5N1 Cases
3 articles · Updated · Medical Daily · Jul 1
Summary
71 confirmed U.S. H5N1 human cases and 2 deaths through early 2026 remain tied to direct animal contact, with no confirmed person-to-person spread.
H5N1 is the main U.S. concern because it continues circulating in dairy cattle, poultry and wild animals, putting dairy and poultry workers without PPE at the clearest risk.
H5N2 has produced only 1 known human case — a fatal 2024 infection in Mexico — while H9N2 caused 5 global cases in Q1 2026, all linked to poultry exposure and none to onward transmission.
CDC and WHO still rate public risk from all 3 strains as low, but keep intensive surveillance in place because repeated animal-to-human infections create chances for mutations or recombination that could enable efficient human spread.
Is the US policy on poultry vaccination gambling with a future human pandemic as the H5N1 virus adapts to mammals?
Why does the US refuse to vaccinate poultry against bird flu, despite having effective vaccines and seeing France's success?
H5N1 in 2026: Economic, Policy, and Public Health Impacts of the Ongoing U.S. Avian Influenza Crisis
Overview
In June 2026, H5N1 resurged in U.S. commercial poultry flocks, continuing an outbreak that has persisted despite major control efforts. The virus spreads to new flocks mainly through wild birds during migration seasons, making eradication difficult. These new detections quickly affected the market, causing immediate concerns about egg supply. After a period of falling egg prices, the loss of more flocks in June is expected to push prices higher in the coming weeks. This situation highlights how ongoing outbreaks and wildlife transmission can disrupt markets and challenge the poultry industry’s stability.